Follow on Twitter Follow on Facebook
Symptom Search   |   Treatment Search   |   Doctor Search   |   Drug Search

Hepatocellular carcinoma Health Article

Advertisement
Marketplace
Licensed from
Page: 1 2 Next >

Definition

Hepatocellular carcinoma is cancer of the liver.

Alternative Names

Primary liver cell carcinoma; Tumor - liver; Liver cancer; Cancer - liver

Causes, incidence, and risk factors

Hepatocellular carcinoma accounts for most liver cancers. This type of cancer occurs more often in men than women. It is usually seen in people ages 50 - 60.

The disease is more common in parts of Africa and Asia than in North or South America and Europe.

Hepatocellular carcinoma is not the same as metastatic liver cancer, which starts in another organ (such as the breast or colon) and spreads to the liver.

In most cases, the cause of liver cancer is usually scarring of the liver (cirrhosis). Cirrhosis may be caused by:

Patients with hepatitis B or C are at risk for liver cancer, even if they do not have cirrhosis.

Symptoms

  • Abdominal pain or tenderness, especially in the upper-right part
  • Easy bruising or bleeding
  • Enlarged abdomen
  • Yellow skin or eyes (jaundice)

Signs and tests

Physical examination may show an enlarged, tender liver.

Tests include:

Some high-risk patients may get periodic blood tests and ultrasounds to see whether tumors are developing.

Treatment

Aggressive surgery or a liver transplant can successfully treat small or slow-growing tumors if they are diagnosed early. However, few patients are diagnosed early.

Chemotherapy and radiation treatments are not usually effective. However, they may be used to shrink large tumors so that surgery has a greater chance of success.

Sorafenib toslate (Nexavar), an oral medicine that blocks tumor growth, is now approved for patients with advanced hepatocellular carcinoma.

Page: 1 2 Next >
Reviewer Info: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.; ADAM Health Illustrated Encyclopedia, 08/09/2009
 
3D Body Maps
Related Learning
Centers
·As a Complication
Advertisement
Back to Top